Compounds are provided that act as potent antagonists of the CCR2 receptor. Animal testing demonstrates that these compounds are useful for treating inflammation, a hallmark disease for CCR2. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR2-mediated diseases, and as controls in assays for the identification of CCR2 antagonists.
所提供的化合物是 CCR2 受体的强效拮抗剂。动物试验证明,这些化合物可用于治疗炎症,而炎症是 CCR2 的标志性疾病。这些化合物通常是芳基磺酰胺衍
生物,可用于药物组合物、治疗 CCR2 介导的疾病的方法,以及用作鉴定 CCR2 拮抗剂的测定中的对照物。